Theragnostics inks AstraZeneca agreement

AuntMinnie.com staff writers
Sep 4, 2019

Molecular radiotherapy developer Theragnostics said it has signed an intellectual property agreement with AstraZeneca.

The agreement allows Theragnostics to develop radiotherapy based on radionuclide-labeled poly (ADP-ribose) polymerase (PARP) inhibitors, a class of oncology drugs that block the PARP enzyme, which cancer cells use in response to DNA damage.
Latest in Radiation Oncology/Therapy
Fuse Oncology Fuse Rx Clinical Workflow Platform
Fuse Oncology expands FuseRx workflow to full radiation oncology team
September 25, 2026
Astro
ASTRO 2026 to center on translating radiotherapy data into dialogue
September 23, 2026
Nuclear Medicine Worker Sm
ASRT opposes proposal to remove ALARA standard from radiation rules
September 22, 2026
Fda Button 400
Recalls stable for radiation oncology tools despite tech advancements
September 18, 2026
Related Stories
2021 09 14 23 49 7847 Business Handshake 400
Molecular Imaging
Theragnostics enters licensing deal with AAA for Ga-68 PET
2020 07 28 23 23 5650 Business Hands Cooperation 400
Molecular Imaging
Theragnostics names two new board directors
2017 09 14 23 05 1167 Cancer Cell 400
Molecular Imaging
Theragnostics, German hospital to study THG-008 for PET
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
AI
AstraZeneca, Qure.ai partner for lung cancer diagnosis
More in Radiation Oncology/Therapy
Fuse Oncology expands FuseRx workflow to full radiation oncology team
By AuntMinnie.com staff writers
The platform streamlines workflows from consult note and treatment intent through simulation, treatment planning, and scheduling.
September 25, 2026
Fuse Oncology Fuse Rx Clinical Workflow Platform
ASTRO 2026 to center on translating radiotherapy data into dialogue
By Will Morton
Radiopharmaceutical therapy will feature in a dedicated hands-on workshop alongside a roundtable.
September 23, 2026
Astro
ASRT opposes proposal to remove ALARA standard from radiation rules
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission's proposed rules are anticipated to take effect in early 2027.
September 22, 2026
Nuclear Medicine Worker Sm
Recalls stable for radiation oncology tools despite tech advancements
By Amerigo Allegretto
While radiation oncology devices using AI or machine learning are increasingly entering the market, recalls may be plateauing.
September 18, 2026
Fda Button 400
Minibeam radiotherapy performs well in first clinical trial
By Will Morton
The technique delivers very high doses of radiation through closely spaced, extremely narrow beams.
September 17, 2026
Radiation oncology medical physicist Michael Grams, MD, holds a device called a tungsten collimator that divides a conventional radiation beam into submillimeter-wide beamlets.
ASTRO issues first radiation therapy guideline for bladder cancer
By AuntMinnie.com staff writers
Bladder preservation should be presented as a curative treatment option alongside radical cystectomy.
September 16, 2026
Astro1
ASTRO urges CMS to address radiation oncology shortfalls
By AuntMinnie.com staff writers
More than two-thirds of radiation oncologists responding to an ASTRO survey this spring reported declines of 10% or more.
September 14, 2026
Astro
Accuray, RaySearch expand collaboration
By AuntMinnie.com staff writers
The new collaboration will focus on increasing adoption of online adaptive radiation therapy.
September 11, 2026
Accuray Astro 2019
UH-WBI use increased during COVID-19 pandemic
By Amerigo Allegretto
The use of ultra-hypofractionated whole-breast irradiation (UH-WBI) increased by five times during the pandemic.
September 11, 2026
Covid 19 Map 400
Radical radiotherapy use rising for treating lung cancer
By Amerigo Allegretto
Radical radiotherapy use nearly doubled between 2010 and 2021 in lung cancer patients and correlates to improved five-year outcomes.
September 10, 2026
Lungs Red 400
Fortis to install first upright proton therapy system in India
By AuntMinnie.com staff writers
The Mevion S250-FIT proton therapy system will be installed at Fortis Memorial Research Institute in Gurugram.
September 8, 2026
India Flag Button 400
DOSIsoft Theranostics joins FNIH precision dosimetry research project
By AuntMinnie.com staff writers
The project aims to establish standardized imaging protocols and reliable absorbed dose measurements for RPT treatment strategies.
September 8, 2026
Radiation Treatment Cancer 400 (3)
Page 1 of 474
Next Page